Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from David Ricks

Eli Lilly stock crushed as weight loss sales, profits, disappoint Wall Street

Eli Lilly's weight loss treatments have powered the company into the top ten list of megacap U.S. stocks.

Analysts reset targets for Eli Lilly shares

Analysts reset targets for Eli Lilly shares

Here's what may happen next for the pharma giant's stock price.

Midday stock movers: Warner Bros. sinks, Nvidia, Rivian, Eli Lilly up

Midday stock movers: Warner Bros. sinks, Nvidia, Rivian, Eli Lilly up

Here are the stocks making the biggest market moves today.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analysts revamp Eli Lilly stock price target ahead of Q2 earnings

Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.

Eli Lilly’s CEO pinpoints the 3-pronged problem big execs face with remote work

Managing a distributed workforce is “the leadership challenge of our decade,” David Ricks, CEO of pharma giant Eli Lilly, said.

‘Hero’ journalist congratulated after Eli Lilly lowers price of insulin after his spoof tweet raised awareness

Eli Lilly’s CEO challenged other pharmaceutical companies to drop insulin prices as well

The Independent UK

US drug maker to slash some insulin prices, expand cost cap

President Joe Biden hails move by Eli Lilly as a ‘big deal’, calling on other manufacturers to also reduce prices.

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Lawmakers and patient advocates have been pressuring drugmakers to take action on soaring drug prices.

Chicago Sun-Times

Diabetes Giant Eli Lilly Slashes Insulin Prices 70% In A Move Its CEO Calls 'Aggressive'

Diabetes Giant Eli Lilly Slashes Insulin Prices 70% In A Move Its CEO Calls 'Aggressive'

Eli Lilly announced a 70% price cut for most of its insulins Wednesday in a move its CEO described as "aggressive." Eli Lilly stock jumped.

Investors Business Daily

Eli Lilly Tops Q4 Earnings Forecast, Lifts 2023 Outlook, On Trulicity Strength

Eli Lilly Tops Q4 Earnings Forecast, Lifts 2023 Outlook, On Trulicity Strength

"Over the course of this critical year, we hope to launch as many as four new medicines for challenging diseases, while advancing our next generation of molecules currently in Phase 3." said CEO David Ricks.

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

The Guardian - US

Eli Lilly Stock Leaps As Trulicity Sales Drive Q1 Earnings Beat, Obesity Drug Trial Data

Eli Lilly Stock Leaps As Trulicity Sales Drive Q1 Earnings Beat, Obesity Drug Trial Data

"We are well-positioned to help address health challenges in areas of significant unmet medical need, such as obesity, Alzheimer's disease and cancer," said CEO David Ricks.

People

Jordan Peterson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

252,730 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play